These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 16134300)

  • 21. [Neurofibromatosis type 1 and associated clinical abnormalities in 27 children].
    Syrbe S; Eberle K; Strenge S; Bernhard MK; Herbertz S; Bierbach U; Hirsch W; Froster UG; Kiess W; Merkenschlager A
    Klin Padiatr; 2007; 219(6):326-32. PubMed ID: 18183640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and genetic aspects of neurofibromatosis 1.
    Jett K; Friedman JM
    Genet Med; 2010 Jan; 12(1):1-11. PubMed ID: 20027112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neurofibromatosis type 1 or Von Recklinghausen's disease].
    Pinson S; Wolkenstein P
    Rev Med Interne; 2005 Mar; 26(3):196-215. PubMed ID: 15777582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatal Retroperitoneal Bleeding in Neurofibromatosis Type 1: A Clinically Occult Complication.
    Voudouri M; Chambers M; Baker ML; Kerr DA
    Am J Forensic Med Pathol; 2023 Mar; 44(1):63-67. PubMed ID: 36398883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unidentified bright objects associated with features of neurofibromatosis 1.
    Szudek J; Friedman JM
    Pediatr Neurol; 2002 Aug; 27(2):123-7. PubMed ID: 12213613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurofibromatosis type 1: a diagnostic mimicker at CT.
    Fortman BJ; Kuszyk BS; Urban BA; Fishman EK
    Radiographics; 2001; 21(3):601-12. PubMed ID: 11353109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
    Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
    Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Von Recklinghausen's disease: experimental models and comparative aspects].
    Turusov VS; Kardeza A; Ribal'ta T
    Arkh Patol; 1996; 58(5):3-13. PubMed ID: 9005821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neurofibromatosis type 1 - description of clinical features and molecular mechanism of the disease].
    Bikowska-Opalach B; Jackowska T
    Med Wieku Rozwoj; 2013; 17(4):334-40. PubMed ID: 24519776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pigment cell-related manifestations in neurofibromatosis type 1: an overview.
    De Schepper S; Boucneau J; Lambert J; Messiaen L; Naeyaert JM
    Pigment Cell Res; 2005 Feb; 18(1):13-24. PubMed ID: 15649148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurofibromatosis without Neurofibromas: Confirmation of a Genotype-Phenotype Correlation and Implications for Genetic Testing.
    Quintáns B; Pardo J; Campos B; Barros F; Volpini V; Carracedo A; Sobrido MJ
    Case Rep Neurol; 2011 Apr; 3(1):86-90. PubMed ID: 21532985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
    Bernier A; Larbrisseau A; Perreault S
    Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occurrence of multiple Cerebral Cavernous Malformations in a patient with Neurofibromatosis type 1.
    Rerat K; Parker F; Nasser G; Vidaud D; Riant F; Tournier-Lasserve E; Denier C
    J Neurol Sci; 2015 Mar; 350(1-2):98-100. PubMed ID: 25702150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deep-seated segmental neurofibromatosis without café au lait spots.
    Ogose A; Hotta T; Imaizumi S; Saito H; Homma T; Takahashi HE
    Skeletal Radiol; 2000 Sep; 29(9):543-7. PubMed ID: 11000302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Syndromes 18. Von Recklinghausen's disease].
    Baart JA; van Hagen JM
    Ned Tijdschr Tandheelkd; 2000 Feb; 107(2):57-9. PubMed ID: 11385791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurofibromatosis-I Presentating with Multiple Spinal and Intracranial Neurofibromas.
    Tripathi S; Pandey CB; Dubey TN; Singh P
    J Assoc Physicians India; 2016 Feb; 64(2):72-74. PubMed ID: 27730789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orthopaedic manifestations of neurofibromatosis type 1: A case report.
    Năstase F; Radaschin DS; Niculeț E; Brădeanu AV; Verenca MC; Nechita A; Chioncel V; Nwabudike LC; Baroiu L; Drima Polea E; Fotea S; Anghel L; Nechifor A; Tatu AL
    Exp Ther Med; 2022 Feb; 23(2):135. PubMed ID: 35069816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of urticaria pigmentosa with café-au-lait spots, neurofibromas and neurofibroma-like neoplasms: a mere coincidence?
    Möhrenschlager M; Engst R; Müller-Weihrich S; Spiessl W; Rüdisser K; Weigl LB; Jessberger B; Braun-Falco M; Abeck D; Ring J
    Dermatology; 2003; 206(4):297-302. PubMed ID: 12771469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Manifestations of the tongue in Neurofibromatosis type 1.
    Bongiorno MR; Pistone G; Aricò M
    Oral Dis; 2006 Mar; 12(2):125-9. PubMed ID: 16476032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Jaffe-Campanacci syndrome or neurofibromatosis type 1: a case report of phenotypic overlap with detection of NF1 gene mutation in non-ossifying fibroma.
    Vannelli S; Buganza R; Runfola F; Mussinatto I; Andreacchio A; de Sanctis L
    Ital J Pediatr; 2020 May; 46(1):58. PubMed ID: 32393377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.